Showing 951 results

Filters Content type: News, Editors' picks, About HIV Topic: Side effects

The most common side effects of anti-HIV drugs are short term and are the result of the body getting used to a new drug. Long-term adverse effects and toxicities are less common.

Child developmental issues

South Africa urgently needs an antiretroviral pregnancy registry

Editor's pick
Spotlight
29 January 2019
HIV treatment

Six advantages of dolutegravir

Editor's pick
Spotlight SA
28 January 2019
New & experimental HIV treatments

South Africa: New safety concerns emerge on latest HIV wonder drug

Editor's pick
Business Day
18 January 2019
Child developmental issues

Efavirenz in pregnancy is at least as safe as other antiretrovirals

News
17 January 2019
Sleep

Sleep Abnormalities Do Not Reverse After Discontinuing Efavirenz

Editor's pick
Infectious Disease Advisor
14 January 2019
Side effects

Do integrase inhibitors raise the risk of obesity?

News
10 January 2019
Health problems in children & young people

Improved liver function, but progressive kidney damage, among children on antiretroviral therapy in Ethiopia

News
2 January 2019
Cardiovascular disease

Italian study shows growth in heart and kidney problems in people living with HIV

News
28 December 2018
HIV treatment

Top 10 HIV Clinical Developments of 2018

Editor's pick
The Body Pro
20 December 2018
Side effects

Doubt cast on link between tenofovir disoproxil and bone fractures

News
7 December 2018
Cardiovascular disease

What triggered my heart attack?

Editor's pick
EATG
19 November 2018
PrEP science

How safe is PrEP? Meta-analysis finds no increased risk of serious side-effects

News
2 November 2018
Cardiovascular disease

Cardiovascular Risk Unclear for HIV Patients on Dolutegravir

Editor's pick
Medscape (requires free registration)
1 November 2018
Child developmental issues

Dolutegravir Use During Pregnancy: What Are the Risks?

Editor's pick
Infectious Disease Advisor
22 October 2018
Injectable & long-acting HIV treatment

Wide range of views about switching to weekly, monthly or biannual ART

News
15 October 2018
Child developmental issues

Efavirenz, but not dolutegravir, linked to neurological problems in children

News
11 October 2018
Child developmental issues

Efavirenz in HIV-positive pregnant women, risk of neurological condition in children

Editor's pick
IDSA press release
5 October 2018
Treatment guidelines

Why the world may force women to choose: No birth control, no ARVs

Editor's pick
Bhekisisa
22 August 2018
Side effects

Neuropsychiatric side-effects lead only 1 in 40 to drop dolutegravir, French study shows

News
22 August 2018
Health problems & ageing

Diarrhoea continues to affect the quality of life of people with HIV in the modern treatment era

News
7 August 2018
Treatment for women

Dolutegravir: update on infant neural tube defects from Botswana

News
24 July 2018
Pregnancy and vertical transmission

Dolutegravir preconception signal: time is up for shoddy surveillance

Editor's pick
HIV i-Base
16 July 2018
Side effects

We Must Talk About Having Diarrhea. I’ll Go First.

Editor's pick
My Fabulous Disease
16 July 2018
Pregnancy and vertical transmission

Dolutegravir: need to consider all pros and cons before switching in pregnancy

Editor's pick
HIV i-Base
11 July 2018